Overview

Leucine in Midlife Depression

Status:
RECRUITING

Trial end date:
2029-06-01

Target enrollment:

Participant gender:

Summary

The study aims to investigate the effects of a 6-week leucine challenge on brain chemistry, connectivity, and behavior in people with midlife depression. The researchers will compare the leucine and an active comparator arm (lysine) for 6 weeks.

Phase:

PHASE2

Details

Lead Sponsor:

Emory University

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Leucine
Lysine